Tuxarin is a Oral Tablet, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Mainpointe Pharmaceuticals. The primary component is Codeine Phosphate; Chlorpheniramine Maleate.
Product ID | 71269-040_7ecc03e0-b56e-4ac0-9f91-bd245ef56f32 |
NDC | 71269-040 |
Product Type | Human Prescription Drug |
Proprietary Name | Tuxarin |
Generic Name | Codeine Phosphate And Chlorpheniramine Maleate |
Dosage Form | Tablet, Extended Release |
Route of Administration | ORAL |
Marketing Start Date | 2018-10-15 |
Marketing Category | NDA / NDA |
Application Number | NDA206323 |
Labeler Name | Mainpointe Pharmaceuticals |
Substance Name | CODEINE PHOSPHATE; CHLORPHENIRAMINE MALEATE |
Active Ingredient Strength | 54 mg/1; mg/1 |
Pharm Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC],Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2018-10-15 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA206323 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2018-10-15 |
Ingredient | Strength |
---|---|
CODEINE PHOSPHATE | 54.3 mg/1 |
SPL SET ID: | a7cfab67-6087-4ab4-b7cd-4f9295413180 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
TUXARIN 97027082 not registered Live/Pending |
MainPointe Pharmaceuticals, LLC 2021-09-14 |
TUXARIN 86659512 not registered Dead/Abandoned |
Spriaso LLC 2015-06-11 |